Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes

By Jones Michael R.   Mudaliar Sunder   Hernandez-Triana Eric   Unnikrishnan Ambika G.   Lai Yu-Ling   Abby Stacey L.   Misir Soamnauth   Jin Xiaoping   Nagendran Sukumar  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2239-2249

Informa Healthcare

Access to resources Recommend Favorite

Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus

By Jung Jin   Kaku Kohei   Kim Jae   Kim Jung-Ryul   Ko Jae-Wook   Lee Soo-Youn   Huh Wooseong  

Advances in Therapy, Vol. 30, Iss. 11, 2013-11 ,pp. : 1018-1029

Springer Publishing Company

Access to resources Recommend Favorite

Prescribing practices and clinical predictors of glucose‐lowering therapy within the first year in people with newly diagnosed Type 2 diabetes

By  

DIABETIC MEDICINE, Vol. 32, Iss. 12, 2015-12 ,pp. : 1546-1554

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blood Glucose‐lowering Effect of T. procumbens L.: A Pilot Clinical Study in Individuals with Type 2 Diabetes

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 9, 2015-09 ,pp. : 1404-1411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 8, 2015-08 ,pp. : 771-780

John Wiley & Sons Inc

Access to resources Recommend Favorite